Document is current
Any future updates will be listed below
-
Authors
Haluzik, Martin https://orcid.org/0000-0002-0201-6888
Taybani, Zoltan
Araszkiewicz, Aleksandra
Cerghizan, Anca
Mankovsky, Boris
Zuhdi, Agbaria
Malecki, Maciej
- License Information
-
More Information
Article History
Received: 18 April 2024
Accepted: 6 June 2024
First Online: 27 June 2024
Declarations
:
: Martin Haluzik has been an advisory panel member of Novo Nordisk, Eli Lilly, Sanofi, Merck, Pfizer, Astra Zeneca and Berlin-Chemie; has received consulting fees and grants/research support from Sanofi; has received the speakers honoraria for speakers bureau from Sanofi, Novo Nordisk, Eli Lilly, Sanofi, Pfizer, AstraZeneca and Berlin-Chemie. Zoltan Taybani has been an advisory panel member of Boehringer Ingelheim; has been a consultant for AstraZeneca and Novo Nordisk; has received the speakers honoraria for speakers bureau from Sanofi. Aleksandra Araszkiewicz has received lecture fees or advisory board fees from Eli Lilly, Novo Nordisk and Sanofi. Anca Cerghizan has been an advisory panel member of Sanofi, AstraZeneca, Novo Nordisk, Boehringer Ingelheim and Medtronic; has received educational grants from Worwag, Eli Lilly, Novo Nordisk, Sanofi, Servier, Berlin-Chemie, MSD, Terapia, AstraZeneca and Amgen; has participated in clinical studies conducted by Sanofi, MSD, Johnson & Johnson, Berlin-Chemie Menarini, Roche Pharma Holding, AstraZeneca and Novo Nordisk; has received speakers honoraria for speakers bureau from Sanofi, Novo Nordisk, Eli Lilly, MSD, Boehringer Ingelheim, AstraZeneca, BMS, Terapia, Servier, KRKA, Milan, Egis, Medtronic, Medochemie and Gedeon. Boris Mankovsky has received the speakers honoraria for speakers bureau from AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Sanofi, Servier and Bayer; has been a member of advisory board of Sanofi, Bayer, Worwag and Boehringer Ingelheim. Agbaria Zuhdi has received speaker honoraria for advisory board meeting from Sanofi. Maciej Malecki has acted as a consultant or speaker for AstraZeneca, Bayer, Novo Nordisk, Sanofi-Aventis, Lilly, Merck, Boehringer Ingelheim, Mundipharma, Abbott, Dexcom, and Medtronic; has also participated in the National Center for Research and Development CRACoV-HHS project.
: This expert opinion manuscript is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
